239 filings
Page 6 of 12
8-K
8a5e 5xo57
19 May 21
Organicell Signs an Exclusive Distribution Agreement
9:01am
8-K
611u23 5pbe9b2k9iu6a
11 May 21
Organicell Receives Approval in Pakistan for the use of ZofinTM for Compassionate Grounds for COVID-19
9:02am
8-K
kvl4zim1ajlzjrlh2d
4 May 21
Organicell Begins Up-Listing Process On NASDAQ Exchange
9:00am
8-K
v01hv6yd
28 Apr 21
Organicell Announces Positive Results Of Initial COVID-19 Zofin™ Patient Trial In India And Trial Expansion
9:00am
8-K
6y7ow67 pc
22 Apr 21
Organicell Completes Enrollment for its Expanded Access Trial
8:30am
8-K
97tdglgyu 39fxfv629
21 Apr 21
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis
8:30am
8-K
ip4zlp
14 Apr 21
Other Events
8:30am
8-K
xvw tzngmh35kpjmhrf2
23 Mar 21
Organicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic Potential
8:30am
8-K
6zwb dqnrj0ex49
18 Mar 21
Other Events
8:30am
NT 10-K
qodkgtmi4awms9puk
29 Jan 21
Notice of late annual filing
4:02pm
8-K
bmsvhv5l1swiq70i9p
28 Jan 21
Other Events
9:00am
DEF 14C
xog lc8u590y0ax
19 Jan 21
Information statement
7:11am
8-K
5b2 ta25mt
12 Jan 21
Regulation FD Disclosure
4:05pm
PRE 14C
ms0s05 v7f8gbwt
5 Jan 21
Preliminary information
4:10pm
8-K
odon9tqorfsd89id1n1
28 Dec 20
Unregistered Sales of Equity Securities
12:00am
8-K
vi888cwcapigbku s5
22 Dec 20
Organicell Regenerative Medicine, Inc. Becomes Current with Sec Reporting Requirements
9:00am